Dose response for adjuvant chemotherapy of breast cancer: experimental and clinical considerations.
Frei
E
E
Dana-Farber Cancer Institute, Boston, MA 02115.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015201:Meta-Analysis as Topic; D008954:Models, Biological; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil